February 7, 2018 | German pharmaceutical giant Merck has launched an innovation lab through its subsidiary Qlight Nanotech at the Edward J. Safra campus of Hebrew University of Jerusalem, the company announced on Monday. The lab “emphasizes Merck’s commitment to Israel and the collaboration with the Hebrew University, with the aim to expand its developmental efforts in nanotechnologies and materials,” a statement said. Qlight Nanotech was established through Yissum, the technology transfer company of Hebrew University and is supported by the Israel Innovation Authority. It partners Hebrew U’s Professor Uri Banin and Merck. Qlight was recognized in 2014 as “Nanotechnology Company of the Year,” by the Chief Scientist of Israel and was fully acquired by Merck in mid-2015. It focuses on the research and development of cadmium-free quantum materials for use in display applications and supports Merck’s development in liquid crystal display materials and OLED materials.